Otsuka Pharmaceutical Co. Newsletter
-
New State of Sweat Index Reveals Vast Majority of High-Heat Workers Suffer Dehydration Symptoms; Many May Not Be Hydrating Optimally
06 Aug 2025 16:05 GMT
… solutions developed over decades by Otsuka Pharmaceutical to offer a precisely formulated …
-
Esperion Reports Second Quarter 2025 Financial Results and Provides Business Update
05 Aug 2025 10:00 GMT
… Company’s partner in Japan, Otsuka Pharmaceutical Co., Ltd. is on track …
-
Schizophrenia Drugs Market Research Report 2025-2035, Competitive Analysis of Prominent Players - Novartis, Johnson & Johnson, Eli Lilly and Co, Otsuka Pharmaceutical, and Pfizer - ResearchAndMarkets.com
28 May 2025 19:29 GMT
… , Inc.
Eli Lilly and Company
Otsuka Pharmaceutical Co., Ltd.
Pfizer, Inc.
Key …
-
Otsuka Pharmaceutical discovers new CSF1R inhibitors
27 May 2025 20:06 GMT
Neurology/psychiatric
Otsuka Pharmaceutical Co. Ltd. has described macrophage …
-
NPPA fixes retail prices for Otsuka Pharmaceutical's 3 formulations
09 May 2025 20:46 GMT
… fixed the retail price of Otsuka Pharmaceutical's 3 scheduled … Authority had received applications from Otsuka Pharmaceutical India Private Limited for separate … deliberated upon the applications of Otsuka Pharmaceutical India Private Limited and approved …
-
ICU Medical and Otsuka Pharmaceutical Factory Partner to Bolster IV Solutions Manufacturing in North America
02 May 2025 20:45 GMT
ICU Medical, Inc. and Otsuka Pharmaceutical Factory announce the formation of …
-
Otsuka Pharmaceutical extends a hand of support to ‘sandwich caregivers’
14 Apr 2025 18:14 GMT
In recent years, Otsuka Pharmaceutical has made a public, concerted …
-
Sky Labs partners with Otsuka Pharmaceutical to expand global distribution of smart ring blood pressure monitor
22 Jan 2025 02:45 GMT
… (MOU) with Japan's Otsuka Pharmaceutical to discuss the overseas distribution … ).
"The partnership discussions with Otsuka Pharmaceutical hold significant potential to impact …
-
Aurinia (AUPH) Q2 Revenue Jumps 22%
01 Aug 2025 05:34 GMT
… of LUPKYNIS, its partnership with Otsuka Pharmaceutical for international markets, and investment …
-
Merck Sharp & Dohme and Otsuka Pharmaceutical discover TP53 mutant activators
26 Sep 2024 18:55 GMT